# Dakhil, Dr Shaker, Wichita, KS – FDA Inspections

Source: https://www.keypedia.com/companies/dakhil-dr-shaker/ff880691-4af7-4e7b-ac3d-7c9c33c6bc2a

> Inspection records and compliance data for Dakhil, Dr Shaker in Wichita, Kansas. 6 FDA inspections on record, last inspected April 26, 2024.

---

## Details

- Name: Dakhil, Dr Shaker
- FEI Number: 3007381886
- Address Line 1: 818 N Emporia St Ste 403
- City: Wichita
- State: Kansas
- Zip Code: 67214
- Country Name: United States
- Address: 818 N Emporia St Ste 403, Wichita, Kansas 67214, United States
- Country: United States

## Related Documents

- FDA Inspection 1237501 - Dakhil, Dr Shaker - 2024-04-26 — classification: No Action Indicated (NAI), source: FDA, date: April 26, 2024
- FDA Inspection 1143106 - Dakhil, Dr Shaker - 2021-05-21 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 21, 2021
- [483 - Dakhil, Dr Shaker - 2021-05-10](https://www.keypedia.com/records/483/dakhil-dr-shaker/9d5f158c-86ce-4bcb-bc53-e2a61cc6bf22) — source: FDA, date: May 10, 2021
- [FDA Inspection 945734 - Dakhil, Dr Shaker - 2015-10-08](https://www.keypedia.com/records/fda_inspections/dakhil-dr-shaker/46df6c9d-43e7-45bb-8873-8fe39dcc7061) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 8, 2015
- [FDA Inspection 771967 - Dakhil, Dr Shaker - 2012-03-26](https://www.keypedia.com/records/fda_inspections/dakhil-dr-shaker/23c071b2-d809-43d8-bbe3-d3721e35a63a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 26, 2012
- FDA Inspection 662659 - Dakhil, Dr Shaker - 2010-05-13 — classification: No Action Indicated (NAI), source: FDA, date: May 13, 2010
- FDA Inspection 604425 - Dakhil, Dr Shaker - 2009-07-22 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 22, 2009

## Related Companies

- [Pharmacyclics LLC](https://www.keypedia.com/companies/pharmacyclics-llc/ac914c47-3023-4974-a8f2-6241d0db58b8)
- [Janssen Pharmaceuticals, dba Actelion Pharmaceutical](https://www.keypedia.com/companies/janssen-pharmaceuticals-dba-actelion-pharmaceutical/8d00c775-7a8c-41d5-aa2d-f2154459469d)
- [Rajinder S. Shiwach, M.D.](https://www.keypedia.com/companies/rajinder-s-shiwach-md/1c35f8c6-ef47-4802-b976-011300458fec)
- [SC Johnson Professional USA, Inc.](https://www.keypedia.com/companies/sc-johnson-professional-usa-inc/e9b50d00-3095-4f01-9e05-4f21adc9812a)
- [Andrew C Sedillo, MD](https://www.keypedia.com/companies/andrew-c-sedillo-md/4d92fceb-05ed-4140-ab2f-36edf0630a9f)
- [Dario D. Altamirano, DO](https://www.keypedia.com/companies/dario-d-altamirano-do/3edb2aaf-26c5-417d-bd2a-35cb8d56cfc2)
- [Imaging Endpoints II, LLC.](https://www.keypedia.com/companies/imaging-endpoints-ii-llc/fcd4f5a9-856c-404f-b6f1-0fa2cb3c88f7)
- [Amneal Pharmaceuticals, Llc](https://www.keypedia.com/companies/amneal-pharmaceuticals-llc/1727fcb2-2120-4a7c-a93b-a52aa106268f)
- [Arifulla Khan MD](https://www.keypedia.com/companies/arifulla-khan-md/311edd91-40e3-4296-9283-8ea2b60de005)
- [Upsher-Smith Laboratories, LLC](https://www.keypedia.com/companies/upsher-smith-laboratories-llc/abe71588-9a29-43ec-9663-eabd373c78c5)

## Related Officers

- [Byungja E. Marciante](https://www.keypedia.com/people/byungja-e-marciante/5d1f2927-9017-4ab6-8ad2-521e340ef14f)
